article thumbnail

Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More

Xconomy

An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. The market for drugs for rare or “orphan” diseases continues to grow.

Pricing 97
article thumbnail

Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand

Xconomy

If you missed it, you’ll have to wait until 2024 for the next one. In these politically divided times, Americans this week found near universal agreement on one thing: A celestial event that plunges a summer day into temporary darkness is a captivating experience. The totality of the solar eclipse lasted less than 3 minutes.

Pricing 49